OPTIONS XII for the Control of Influenza
Brisbane, Australia | September 2024
|
Manuscript
|
European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Barcelona, Spain | April 2024
|
ESMO Immuno-Oncology (IO) Annual Congress
Geneva, Switzerland | December 2023
- Discovery of a Novel, Dual CD73 & PD-1 Targeting Multispecific Drug Fc-Conjugate (DFC) for the Treatment of Cancer [Poster] [Abstract]
- Discovery of CBO421, a First-in-Class Drug Fc-Conjugate (DFC), Targeting CD73 in Cancer [Poster] [Abstract]
|
Society for Immunotherapy of Cancer (SITC)
San Diego, CA | November 2023
- Discovery of CBO421, a First-in-Class Drug Fc-conjugate (DFC), Targeting CD73 in Cancer [Poster] [Abstract]
|
Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit
Boston, MA | June 2023
|
International Society for Influenza and Other Respiratory Virus Diseases (ISIRV)
Seattle, WA | May 2023
|
ESMO Targeted Anticancer Therapies
Paris, France | March 2023
|
ESWI
Keynote Lecture | December 2020
|
Manuscript
|
IDWeek
Washington, D.C. | October 2019
|
ASM Microbe
San Francisco, CA | June 2019
|
ECCMID
Amsterdam | April 2019
|